
Sign up to save your podcasts
Or


(New/bonus content starts at 24:11. First part of episode originally aired October 5, 2021.)
This week, Radio Advisory is bringing you an encore of Ep. 91: We need to talk about maternal health in America, where host Rachel (Rae) Woods invites Advisory Board Expert Darby Sullivan and Optum Director of social responsibility Callie Chamberlain to discuss the dire state of maternal health in America.
Following the original episode, in a special bonus segment, host Rae Woods brings back Advisory Board health equity expert Darby Sullivan and invites women’s health expert Gaby Marmolejos to discuss why maternal health, and women’s health more broadly, are only getting worse. In the conversation, they discuss what is driving poor maternal outcomes and why there needs to be a massive shift in how the industry thinks about maternal health moving forward.
This episode was recorded before the FDA approved Zurzuvae (zuranolone), the first ever pill to treat post-partum depression. Postpartum depression is a condition that affects one in eight new mothers. Previously, the only treatment available was an IV infusion approved by the FDA, which required patients to be in the hospital for 2.5 days. The move underscores the industries' need to focus on behavioral health in the postpartum period and on women’s health more broadly.
Links:
Learn more about Advisory Board On-Demand Courses
Visit advisory.com/workforce to get research and insights that will help you understand the current challenges providers are facing and learn how technology – including platforms you may already have – can address healthcare's biggest staffing and care delivery challenges.
Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.
By Advisory Board4.8
171171 ratings
(New/bonus content starts at 24:11. First part of episode originally aired October 5, 2021.)
This week, Radio Advisory is bringing you an encore of Ep. 91: We need to talk about maternal health in America, where host Rachel (Rae) Woods invites Advisory Board Expert Darby Sullivan and Optum Director of social responsibility Callie Chamberlain to discuss the dire state of maternal health in America.
Following the original episode, in a special bonus segment, host Rae Woods brings back Advisory Board health equity expert Darby Sullivan and invites women’s health expert Gaby Marmolejos to discuss why maternal health, and women’s health more broadly, are only getting worse. In the conversation, they discuss what is driving poor maternal outcomes and why there needs to be a massive shift in how the industry thinks about maternal health moving forward.
This episode was recorded before the FDA approved Zurzuvae (zuranolone), the first ever pill to treat post-partum depression. Postpartum depression is a condition that affects one in eight new mothers. Previously, the only treatment available was an IV infusion approved by the FDA, which required patients to be in the hospital for 2.5 days. The move underscores the industries' need to focus on behavioral health in the postpartum period and on women’s health more broadly.
Links:
Learn more about Advisory Board On-Demand Courses
Visit advisory.com/workforce to get research and insights that will help you understand the current challenges providers are facing and learn how technology – including platforms you may already have – can address healthcare's biggest staffing and care delivery challenges.
Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

38,473 Listeners

4,000 Listeners

21,210 Listeners

2,441 Listeners

56,450 Listeners

499 Listeners

9,172 Listeners

9,245 Listeners

190 Listeners

9,709 Listeners

396 Listeners

705 Listeners

620 Listeners

1,221 Listeners

330 Listeners